Finnish biotech startup R2therapies unveils prognostic key for Alzheimer’s

Presenting Health Incubator Helsinki batch 4 companies: Finnish biotech startup R2therapies has recently identified a potential biomarker in the blood of Alzheimer’s disease patients, offering insight into the likelihood of

Finnish biotech startup R2therapies unveils prognostic key for Alzheimer’s Read More »